DexCom Watchlist

tz-plus logo Pivotal Point Tracking DexCom (DXCM): Medical Technology Specialist Shines with Q2 Numbers - 13% Revenue Increase from Accurate Blood Sugar Monitoring

W. Zussner
Reading Time: 1 minute

Dexcom is a medical technology specialist for continuous glucose monitoring systems. The devices enable diabetics and pre-diabetic patients to monitor their blood sugar levels accurately in real time without annoying needle sticks. The company benefits from the globally increasing demand for modern glucose sensors like the G7 and the over-the-counter Stelo biosensor. On July 31, a strong Q2 report triggered a jump in the stock price. Revenue rose by 13% compared to the previous year to $1.308 billion. Net income climbed significantly to $249.1 million....

Read this article now with a free account.

Your benefits:

  • Every month, you can read 5 articles from the premium section for free.
  • Monthly 2 trial issues of the Trader newspaper for free.
  • Create a personal watchlist with an overview of news about your stock.
Trader Times
Free account
Here we go!
Image 1Image 2Image 3

Already registered? Log In